Meprobamate
- Product NDC
- 69097-975
- 11-digit product format
- 690970975
- Labeler code
- 69097
- Product ID
- 69097-975_1fe09b66-c58f-4d50-8932-96f52bda4bcb
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Meprobamate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Cipla USA Inc.
- Application
- ANDA040797
- Marketing category
- ANDA
- Marketing start
- 2021-06-07
- Substance
- MEPROBAMATE
- Active strength
- 400 mg/1
- DEA schedule
- CIV
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Meprobamate
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| MEPROBAMATE | 400 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 9I7LNY769Q |
| Rxcui | 197928, 197929 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 69097-975-07 | Meprobamate | 100 in 1 BOTTLE | TABLET | 100 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 69097-975 | MEPROBAMATE TABLET [CIPLA USA INC.] | 1 | Current NDC, Legacy NDC, 1 package rows | 20210620_17d814e2-b277-4dce-8615-e7fd7cab773f.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 69097-975-07 | 69097097507 | 100 TABLET in 1 BOTTLE (69097-975-07) | 100 tablet | 2021-06-07 | 0000-00-00 | No | No | Current |